Literature DB >> 25663993

p42.3 promotes cell proliferation and invasion in human Renal-Cell Carcinoma.

Pei-Hua Li1, Wen-Jia Cao2, Lin-Lin Mao2, Hui Huang2, Jun-Nian Zheng3, Dong-Sheng Pei2.   

Abstract

p42.3 is a tumor-specific gene and found to be over-expressed in many tumor cell lines and primary tumor tissues. It plays a significant role in neoplastic transformation and tumor progression. To date, the association between p42.3 and Renal-Cell Carcinoma (RCC) has not been reported. This study investigated the biological effects and mechanisms of p42.3 in RCC progression. In this study, we found that p42.3 is overexpressed in various kinds of RCC cells, and knockdown of p42.3 dramatically reduced cell proliferation and invasion in vitro. Our studies revealed that overexpression of p42.3 accelerates the epithelial-mesenchymal transition (EMT) progression and induces RCC cells proliferation and invasion. Further studies show that p42.3 may involve in activation of β-catenin and participate in RCC cell invasion. Combined, these data indicate that p42.3 contributes to promoting RCC cells proliferation and invasion through accelerates the EMT progression and β-catenin activation.

Entities:  

Keywords:  E-cadherin; RCC; cell invasion; p42.3; β-catenin

Year:  2014        PMID: 25663993      PMCID: PMC4307440     

Source DB:  PubMed          Journal:  Int J Clin Exp Med        ISSN: 1940-5901


  27 in total

1.  Centrosomal Chk2 in DNA damage responses and cell cycle progression.

Authors:  Amnon Golan; Elah Pick; Lyuben Tsvetkov; Yasmine Nadler; Harriet Kluger; David F Stern
Journal:  Cell Cycle       Date:  2010-07-01       Impact factor: 4.534

Review 2.  Renal-cell carcinoma.

Authors:  Herbert T Cohen; Francis J McGovern
Journal:  N Engl J Med       Date:  2005-12-08       Impact factor: 91.245

Review 3.  Epithelial-mesenchymal transitions in development and disease.

Authors:  Jean Paul Thiery; Hervé Acloque; Ruby Y J Huang; M Angela Nieto
Journal:  Cell       Date:  2009-11-25       Impact factor: 41.582

Review 4.  Regulatory networks defining EMT during cancer initiation and progression.

Authors:  Bram De Craene; Geert Berx
Journal:  Nat Rev Cancer       Date:  2013-02       Impact factor: 60.716

Review 5.  Prognostic factors in renal cell carcinoma.

Authors:  Alessandro Volpe; Jean Jacques Patard
Journal:  World J Urol       Date:  2010-04-03       Impact factor: 4.226

6.  Inhibition of Ki-67 in a renal cell carcinoma severe combined immunodeficiency disease mouse model is associated with induction of apoptosis and tumour growth inhibition.

Authors:  Ingo Kausch; Hai Jiang; Nina Ewerdwalbesloh; Christian Doehn; Stefan Krüger; Georg Sczakiel; Dieter Jocham
Journal:  BJU Int       Date:  2005-02       Impact factor: 5.588

Review 7.  The role of epithelial-mesenchymal transition in cancer pathology.

Authors:  Marcello Guarino; Barbara Rubino; Gianmario Ballabio
Journal:  Pathology       Date:  2007-06       Impact factor: 5.306

8.  p42.3: a promising biomarker for the progression and prognosis of human colorectal cancer.

Authors:  Xiao-Sun Yuan; Yi Zhang; Xiao-Ya Guan; Bin Dong; Min Zhao; Lin-Lin Mao; You-Yong Lu; Xiu-Yun Tian; Chun-Yi Hao
Journal:  J Cancer Res Clin Oncol       Date:  2013-04-11       Impact factor: 4.553

Review 9.  The role of cell adhesion molecules in the progression of colorectal cancer and the development of liver metastasis.

Authors:  Konstantinos A Paschos; David Canovas; Nigel C Bird
Journal:  Cell Signal       Date:  2009-01-07       Impact factor: 4.315

10.  RUNX3 suppresses migration, invasion and angiogenesis of human renal cell carcinoma.

Authors:  Feifei Chen; Jin Bai; Wang Li; Pengjin Mei; Hui Liu; Linlin Li; Zhenqiang Pan; Yongping Wu; Junnian Zheng
Journal:  PLoS One       Date:  2013-02-14       Impact factor: 3.240

View more
  5 in total

1.  Depletion of p42.3 gene inhibits proliferation and invasion in melanoma cells.

Authors:  Hui Liu; Min Zhu; Zhongwu Li; Yan Wang; Rui Xing; Youyong Lu; Weicheng Xue
Journal:  J Cancer Res Clin Oncol       Date:  2017-01-16       Impact factor: 4.553

2.  MiR-486-5p specifically suppresses SAPCD2 expression, which attenuates the aggressive phenotypes of lung adenocarcinoma cells.

Authors:  Desheng Wei
Journal:  Histol Histopathol       Date:  2022-04-25       Impact factor: 2.130

Review 3.  The Function and Regulation of SAPCD2 in Physiological and Oncogenic Processes.

Authors:  Amy L Baker; Liqin Du
Journal:  J Cancer       Date:  2022-04-18       Impact factor: 4.478

4.  Overexpression of SAPCD2 correlates with proliferation and invasion of colorectal carcinoma cells.

Authors:  Yage Luo; Lili Wang; Wenwen Ran; Guangqi Li; Yujing Xiao; Xiaonan Wang; Han Zhao; Xiaoming Xing
Journal:  Cancer Cell Int       Date:  2020-02-06       Impact factor: 5.722

5.  Silencing SAPCD2 Represses Proliferation and Lung Metastasis of Fibrosarcoma by Activating Hippo Signaling Pathway.

Authors:  Bowen Zhu; Yanqin Wu; Lizhi Niu; Wang Yao; Miao Xue; Hongyu Wang; Jianyong Yang; Jiaping Li; Wenzhe Fan
Journal:  Front Oncol       Date:  2020-12-15       Impact factor: 6.244

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.